About this trial
Chronic respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD), are a leading cause of death globally. These diseases not only contribute significantly to mortality but also lead to a decline in physical capacity, limiting daily activities and perpetuating a vicious cycle of deconditioning. Dyspnea (shortness of breath) is a major symptom, seen in 56 to 98% of COPD patients, and is linked to decreased exercise tolerance and muscle dysfunction. It often leads to reduced physical activity, further worsening respiratory function and quality of life. Dyspnea severity is associated with increased mortality, hospitalizations, and anxiety. The main therapeutic approach for these patients is pulmonary rehabilitation, which improves exercise tolerance, quality of life, and reduces hospitalizations and exacerbations. However, dyspnea limits exercise and is often a barrier to continued physical activity.
Virtual reality (VR) technology has shown promise in managing symptoms like pain, anxiety, and dyspnea by providing a distraction. Studies suggest that VR can improve dyspnea and anxiety, particularly in patients hospitalized for conditions like COVID-19. However, research on VR's immediate effects on exercise capacity is limited, with most studies focusing on non-immersive exergames rather than immersive VR. The potential of VR to improve exercise tolerance in patients with chronic respiratory diseases remains uncertain. Our study aims to test this hypothesis through a randomized crossover trial to assess VR's impact on dyspnea and exercise tolerance in these patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient aged 18 years or older
Patient with a chronic respiratory disease requiring pulmonary rehabilitation
Patient with dyspnea assessed as mMRC ≥ 0 (Annex 3)
Patient undergoing pulmonary rehabilitation at the Paris Saint-Joseph Hospital
Disqualifiers
Contraindications for an endurance reconditioning program (neurodegenerative diseases, severe neurological deficits, unstable cardiovascular diseases)
History of motion sickness, vertigo, vestibular impairment, labyrinthitis
History of seizures or other neurological or psychiatric comorbidities
Severe visual impairments
Trial design
Crossover
Treatments tested in this trial
virtual reality
Other interventionthe patient will wear a VR mask during the session
Treatment groups
Trial outcomes
Primary outcomes
Effort duration
Compare the total duration of effort during a constant-load test on a cycle ergometer between rehabilitation with VR immersion and rehabilitation alone. Total duration of sustained effort during a constant-load test (in seconds)."
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: